Where We Are Now
World's most functional canine BCI
Launch of clinical pilot with three hospitals in KA, India
3000 samples - largest breath-based multi-cancer study in the world.
First cyber-enhanced detection with patent-pending canine BCIs.
Results by June 2024.
Letter-of-intent from national oncology provider
Partnership discussions with other clients - hospital chains and insurance companies.
Breathe easy.
Powered by Dognosis.
A Single Vigilomics Center.
Number of tests
10Cr (3200/day)
6Cr
2000
Total expected savings from early treatment
Total expected savings from early treatment
Values
Animals As Partners
Medicine centered
Science Driven
EY India 2022 Report
5Cr+ Cases
5.8% CAGR.
80% of cases detected too late.
1Cr+ deaths.
Five-year Survival Rate
Survival Rate (%)
Advanced stage
Early stage
Lung
Cancer
Oral
Cancer
Breast
Cancer
Cervical
Cancer
0
20
40
60
80
100
Cancer Screening Is Broken.
How It Works
Breathe
Sniff
Evaluate
Relax/Treat
Kit delivered at home, individual breathes into sample bag for 10 minutes and seals.
Sample arrives at Dognostics center - state-of-the-art highly controlled lab with dogs, sensors, and Al.
Risk-assessment based on DogOS* models shared with health provider.
Health providers make the follow-up decisions, such as further diagnostics and treatment.
No harm to canine co-workers. Only positive reinforcement.
Meeting their gaze as equals.
Patients-first.
Physicians as core stakeholders.
Tailoring data to provide actionable insights.
Constant innovation.
Highest standards of technology development, data, processes.
Transparency.
Uncomfortable, and invasive
Periodic
Organ Specific
High capital and labour costs
Advanced analysis of volatile organic compounds provides an early warning system -
Allowing You To Breath Easy.